Abbott Laboratories (ABT) Retained Earnings (2009 - 2026)

Abbott Laboratories has disclosed Retained Earnings across 18 years of filings, most recently posting $49.8 billion for Q2 2026.

• In Q2 2026, Retained Earnings rose 2.74% year-over-year to $49.8 billion; the TTM figure through Jun 2026 stood at $49.8 billion (up 2.74% YoY), while the FY2025 annual figure was $49.8 billion, up 5.33% from the prior year.
• Retained Earnings came in at $49.8 billion for Q2 2026 at Abbott Laboratories, roughly flat from $50.0 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $50.0 billion in Q1 2026 to a low of -$8.1 billion in Q4 2022.
• Average Retained Earnings over 5 years is $36.3 billion, with a median of $38.2 billion recorded in 2024.
• Year-over-year, Retained Earnings grew 2.63% in 2023 and soared 702.9% in 2024.
• Over 5 years, Retained Earnings stood at -$8.1 billion in 2022, then gained by 2.63% to -$7.8 billion in 2023, then surged by 702.9% to $47.3 billion in 2024, then grew by 5.33% to $49.8 billion in 2025, then grew by 0.03% to $49.8 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $49.8 billion in Q2 2026, $50.0 billion in Q1 2026, and $49.8 billion in Q4 2025.